Global Transdermal Skin Patch Market Size, Growth & Forecast...

Global Transdermal Skin Patch Market Size, Growth & Forecast 2031 | CVMI

2025-08-23 08:19:56 • Visualizações

[Zurich, 23 August 2025] - Clearview Market Insights (CVMI) reports that the global transdermal skin patch market is forecast to rise from USD 7.41 billion in 2024 to USD 12.93 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.4% over seven years. This growth is fueled by a growing shift toward non-invasive, sustained-release drug delivery systems, particularly in the management of chronic conditions.

Request Sample: https://clearviewmarketinsights.com/report-details/global-transdermal-skin-patches-market/

Transdermal patches have become a crucial option for treating pain, hormonal disorders, and neurological diseases. They improve patient compliance—especially among older adults and children—and are benefiting from cutting-edge innovations such as microneedle arrays and smart wearable sensors, which are revolutionizing the way medications are administered.

Leading companies including Hisamitsu Pharmaceutical, Novartis (Sandoz), Teva Pharmaceuticals, and Luye Pharma are ramping up research and development in central nervous system (CNS) and pain relief patches. Hisamitsu has expanded its prescription product offerings in the Americas, Sandoz is advancing a generic rivastigmine patch for Alzheimer’s treatment, Luye is progressing in late-stage trials for a Parkinson’s therapy patch, and Tapemark is collaborating with Nitto on sensor-integrated wearable drug delivery platforms.

From a regional perspective, North America dominates due to favorable insurance and reimbursement for both prescription and OTC patches. Europe is seeing wider use in menopausal hormone therapy, while Asia-Pacific is growing rapidly thanks to rising consumer acceptance and telemedicine support. Latin America and the Middle East & Africa (MEA) benefit from cost-efficient production partnerships and initiatives to enhance chronic care access.

Looking forward, the fusion of sensor technology with advanced polymer materials is set to usher in a new era of connected healthcare solutions. Upcoming innovations include iontophoretic insulin patches, real-time adherence monitoring devices, and temperature-controlled release systems, all of which are poised to accelerate the market’s global expansion.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

Faça Login para curtir, compartilhar e comentar!

Global Transdermal Skin Patch Market Size, Growth & Forecast 2031 | CVMI

"Pro-Russie" ne signifie PAS que la Russie anti-mondialiste poursuit actuellement le même programme de Grande Réinitialisation que l'Occident.

Healthcare EDI Market Gears Up for Significant Expansion, Forecasted to Reach US$ 7.53 Billion by 2030

Participar

Idiomas

Global Transdermal Skin Patch Market Size, Growth & Forecast 2031 | CVMI

"Pro-Russie" ne signifie PAS que la Russie anti-mondialiste poursuit actuellement le même programme de Grande Réinitialisation que l'Occident.

Healthcare EDI Market Gears Up for Significant Expansion, Forecasted to Reach US$ 7.53 Billion by 2030